文献速递生殖医学

人工智能时代的卵母细胞质量:形态学、代谢活性与延时成像的整合

Oocyte quality in the era of AI: integration of morphology, metabolic activity and time-lapse imaging.
PubMed 文献 · Reprod Biomed Online · 2025-10-25

本文综述了当前评估卵母细胞质量的局限,指出除明显异常外形态学与临床结局关联不强,提出人工智能结合培养基分析与显微技术评估代谢状态,有望提升卵母细胞健康评估与选择能力,并辅助优化卵巢刺激方案。

要点

  • 卵母细胞形态学评估除明显异常外与临床结局关联不强。
  • 人工智能与代谢分析显微技术可提供卵母细胞健康的新见解。
  • 改进卵母细胞质量评估有助于咨询预后和优化卵巢刺激。

核心结论

  • 人工智能整合形态学、代谢活性与延时成像有望提升卵母细胞质量评估与选择能力。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 胚胎植入前阶段 viability 的量化已有进展,包括 morphokinetics、biomarkers 和 trophectoderm biopsy 用于 PGT。
  • 卵母细胞 viability 评估仍难以实现,标准方法仍是形态学评估。
  • 除巨大卵等明显异常外,卵母细胞形态学与临床结局关联不强。
  • 卵母细胞捐赠与社会性卵子冷冻的兴起,迫切需要改进配子健康与发育潜能评估。
  • 同一个体连续刺激周期的结局可不同,需量化卵母细胞队列质量并个体化优化刺激方案。

临床怎么用

  • 临床可关注人工智能与代谢分析技术用于卵母细胞健康评估和选择。
  • 可利用改进的卵母细胞质量评估辅助个体化卵巢刺激方案优化。
  • 咨询患者生殖预后时应考虑现有形态学评估的局限性。

局限性

  • 摘要未报告综述的检索范围与纳入标准。
  • 摘要未报告人工智能与代谢分析用于卵母细胞评估的具体性能数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Significant advances have been made with regards to quantifying the viability of the preimplantation-stage human embryo, through the analysis of morphokinetics, quantification of biomarkers and trophectoderm biopsy to facilitate preimplantation genetic testing for aneuploidies (PGT). However, there is still limited capacity to determine the inherent potential of gametes. In particular, assessing the viability of an oocyte has been elusive, and the standard means of determining oocyte quality remains assessing its morphology. Unfortunately, except for grossly abnormal features, such as giant eggs, oocyte morphology is not strongly associated with clinical outcomes. With the rise of oocyte donation and social oocyte freezing, there is an immediate need to improve the ability to determine gamete health and developmental potential to better counsel patients about their reproductive future. Furthermore, the outcomes of successive stimulation cycles can vary within an individual, heightening the need to ensure that the quality of a given oocyte cohort can be quantified and stimulation regimens optimized per patient. Developments in artificial intelligence and in media analysis and microscopies to assess metabolic state could provide valuable insights into oocyte health, thereby increasing the ability to not only improve oocyte health and selection, but also provide a much-needed tool to assist in optimizing ovarian stimulation.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Gardner DK, O'Neill HC, Balaban B, et al. Oocyte quality in the era of AI: integration of morphology, metabolic activity and time-lapse imaging. Reprod Biomed Online. 2025. PMID: 41775050. doi:10.1016/j.rbmo.2025.105363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。